Get access to our best features
Get access to our best features
Published 2 years ago

FDA Committee Unanimous on Two Gene Therapies

Summary by Ground News
The FDA's Cellular, Tissue, and Gene Therapies advisory committee met June 9-10 to consider the two products. The votes each day were unanimously in favor of the products. If approved, beti-cel will be the first potentially curative gene therapy for transfusion-dependent beta-thalassemia.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics